Systematic evaluation of HSV-1 Δ34.5Δ47 as a dual-function platform for attenuated HSV-1 vaccine and heterologous antigen delivery.

Virol Sin · 2026 · PMC13007304 · PMID 41581759

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Additionally, while not statistically significant, the viral gene expression levels in the brains of mice in the HSV-1 Δ34.5Δ47-N group showed a decreasing trend compared with the PBS-injected serum group ( Fig. 6 F).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.